Blueprint Medicines Corporation (BPMC) — Analyst outlook / Analyst consensus target is. Based on 34 analyst ratings, the consensus is bullish — 1 Strong Buy, 17 Buy, 15 Hold, 1 Sell.
The consensus price target is $141.00 (low: $132.00, high: $150.00), representing an upside of 8.9% from the current price $129.46.
BPMC Stock — 12-Month Price Forecast
$141.00
▲ +8.91% Upside
Average Price Target
Based on 34 Wall Street analysts offering 12-month price targets for Blueprint Medicines Corporation, the average price target is $141.00, with a high forecast of $150.00, and a low forecast of $132.00.
The average price target represents a +8.91% change from the last price of $129.46.
Highest Price Target
$150.00
Average Price Target
$141.00
Lowest Price Target
$132.00
BPMC Analyst Ratings
Buy
Based on 34 analysts giving stock ratings to Blueprint Medicines Corporation in the past 3 months
